Replies to post #177 on Catalyst Pharmaceutical Partners (CPRX)

[DonShimoda]

BW,

With the next catalyst several months off (the CPP-115 phase 1 results), the price action is pretty much par for the course. The lack of news combined with low float and lack of liquidity likely means we are range bound for the next few months. Of course, that same low float can also work in ones favor as new buyers discover the stock.